EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
TSX:EXE - Toronto Stock Exchange - CA30224T8639 - Common Stock - Currency: CAD
We assign a fundamental rating of 5 out of 10 to EXE. EXE was compared to 15 industry peers in the Health Care Providers & Services industry. While EXE has a great profitability rating, there are quite some concerns on its financial health. EXE has a decent growth rate and is not valued too expensively. Finally EXE also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
EXE had a positive operating cash flow in the past year.
Each year in the past 5 years EXE has been profitable.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
EXE's Return On Assets of 10.81% is amongst the best of the industry. EXE outperforms 86.67% of its industry peers.
Looking at the Return On Equity, with a value of 61.61%, EXE belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 20.15%, EXE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
EXE had an Average Return On Invested Capital over the past 3 years of 11.40%. This is above the industry average of 8.13%.
The last Return On Invested Capital (20.15%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROIC | 20.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
Looking at the Profit Margin, with a value of 5.23%, EXE is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Profit Margin of EXE has grown nicely.
With a decent Operating Margin value of 7.91%, EXE is doing good in the industry, outperforming 73.33% of the companies in the same industry.
EXE's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 14.04%, EXE is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
EXE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EXE has been increased compared to 1 year ago.
Compared to 5 years ago, EXE has less shares outstanding
EXE has a better debt/assets ratio than last year.
2.2 Solvency
EXE has an Altman-Z score of 2.98. This is not the best score and indicates that EXE is in the grey zone with still only limited risk for bankruptcy at the moment.
EXE's Altman-Z score of 2.98 is fine compared to the rest of the industry. EXE outperforms 80.00% of its industry peers.
EXE has a debt to FCF ratio of 128.12. This is a negative value and a sign of low solvency as EXE would need 128.12 years to pay back of all of its debts.
The Debt to FCF ratio of EXE (128.12) is comparable to the rest of the industry.
A Debt/Equity ratio of 2.16 is on the high side and indicates that EXE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.16, EXE is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Altman-Z | 2.98 |
ROIC/WACC2.96
WACC6.8%
2.3 Liquidity
EXE has a Current Ratio of 0.84. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Current ratio of 0.84. This is comparable to the rest of the industry: EXE outperforms 53.33% of its industry peers.
EXE has a Quick Ratio of 0.84. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Quick ratio of 0.84. This is comparable to the rest of the industry: EXE outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 115.90% over the past year.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
The Revenue has grown by 9.38% in the past year. This is quite good.
Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 5.31% on average per year.
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
3.2 Future
EXE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.74% yearly.
The Revenue is expected to grow by 4.74% on average over the next years.
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.74%
Revenue Next Year8.95%
Revenue Next 2Y6.76%
Revenue Next 3Y5.17%
Revenue Next 5Y4.74%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.93, EXE is valued correctly.
EXE's Price/Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 86.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of EXE to the average of the S&P500 Index (27.30), we can say EXE is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.10, which indicates a correct valuation of EXE.
Based on the Price/Forward Earnings ratio, EXE is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, EXE is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.93 | ||
| Fwd PE | 15.1 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EXE is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
EXE's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 494.91 | ||
| EV/EBITDA | 8.57 |
4.3 Compensation for Growth
EXE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.7
EPS Next 2Y4.74%
EPS Next 3Y7.81%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 3.80%.
Compared to an average industry Dividend Yield of 3.22, EXE pays a better dividend. On top of this EXE pays more dividend than 86.67% of the companies listed in the same industry.
EXE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.8% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has paid a dividend for at least 10 years, which is a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EXE pays out 51.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.91%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
TSX:EXE (7/11/2025, 7:00:00 PM)
13.22
-0.03 (-0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.58%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.11B
Analysts74
Price Target16.41 (24.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.8% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP51.91%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)18.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.93 | ||
| Fwd PE | 15.1 | ||
| P/S | 0.75 | ||
| P/FCF | 494.91 | ||
| P/OCF | 22.04 | ||
| P/B | 8.85 | ||
| P/tB | 184.62 | ||
| EV/EBITDA | 8.57 |
EPS(TTM)0.83
EY6.28%
EPS(NY)0.88
Fwd EY6.62%
FCF(TTM)0.03
FCFY0.2%
OCF(TTM)0.6
OCFY4.54%
SpS17.58
BVpS1.49
TBVpS0.07
PEG (NY)N/A
PEG (5Y)0.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROCE | 26.66% | ||
| ROIC | 20.15% | ||
| ROICexc | 26.88% | ||
| ROICexgc | 42.25% | ||
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% | ||
| FCFM | 0.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexcg growth 3Y72.34%
ROICexcg growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score7
Asset Turnover2.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 143.57% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 9.47 | ||
| Cash Conversion | 33.51% | ||
| Profit Quality | 2.9% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 2.98 |
F-Score7
WACC6.8%
ROIC/WACC2.96
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.74%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
Revenue Next Year8.95%
Revenue Next 2Y6.76%
Revenue Next 3Y5.17%
Revenue Next 5Y4.74%
EBIT growth 1Y90.12%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-5.03%
EBIT Next 3Y4.16%
EBIT Next 5Y2.88%
FCF growth 1Y102.3%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y173.94%
OCF growth 3Y31.32%
OCF growth 5Y26.02%